首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Nanoparticle-encapsulated P2X(7) receptor antagonist in a pH-sensitive polymer as a potential local drug delivery system to acidic inflammatory environments
【24h】

Nanoparticle-encapsulated P2X(7) receptor antagonist in a pH-sensitive polymer as a potential local drug delivery system to acidic inflammatory environments

机译:pH敏感聚合物中的纳米颗粒封装的P2X(7)受体拮抗剂,作为酸性炎症环境的潜在局部药物递送系统

获取原文
获取原文并翻译 | 示例
           

摘要

We have developed nanoparticles of anti-inflammatory P2X(7) receptor antagonist encapsulated in a pH-sensitive polymer, poly(tetrahydropyran-2-yl methacrylate) (poly(THPMA)), as a potential local drug delivery system to target to acidic inflammatory environments, in which P2X(7) receptors are implicated in the pathology of inflammation via the activation of immune cells. The nanoparticles were prepared using single emulsion methods, also their size and shape were confirmed by microscopy and spectroscopy, etc. The profiles of the pH-dependent degradation, release of antagonist and biological activities were investigated. The nanoparticles that encapsulated the 3,5-dichloropyridine derivative (2) with poly (THPMA), were observed to be more slowly cleaved than the blank nanoparticles. Moreover, the free P2X(7) receptor antagonists potently inhibited the receptor activation, whereas the nanoparticles of the 3,5-dichloropyridine derivative (2) encapsulated poly(THPMA) exhibited much lower P2X(7) antagonistic activity through sustained encapsulation. Thus, the nanoparticles of the 3,5-dichloropyridine derivative (2) encapsulated poly(THPMA) may be utilized to develop a pH-sensitive local drug delivery system for controlled release of anti-inflammatory therapeutics in acidic physiological environments. (C) 2015 Elsevier Ltd. All rights reserved.
机译:我们已经开发了一种抗炎P2X(7)受体拮抗剂的纳米颗粒,该颗粒包裹在pH敏感的聚合物聚甲基丙烯酸四氢吡喃-2-基酯(聚(THPMA))中,作为靶向酸性炎症的潜在局部药物递送系统在这种环境中,P2X(7)受体通过激活免疫细胞参与炎症病理。采用单乳液法制备了纳米颗粒,并通过显微镜和光谱学等方法证实了它们的大小和形状。研究了pH依赖性降解,拮抗剂释放和生物活性的概况。观察到用聚(THPMA)包裹3,5-二氯吡啶衍生物(2)的纳米粒子比空白纳米粒子的裂解速度更慢。此外,免费的P2X(7)受体拮抗剂有效地抑制了受体的激活,而3,5-二氯吡啶衍生物(2)包封的聚(THPMA)的纳米粒子通过持续包封表现出低得多的P2X(7)拮抗活性。因此,可以将3,5-二氯吡啶衍生物(2)包封的聚(THPMA)的纳米颗粒用于开发pH敏感的局部药物递送系统,以在酸性生理环境中控制释放消炎治疗剂。 (C)2015 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号